Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mirum Pharmaceuticals (MIRM) Interest & Investment Income: 2019-2024

Historic Interest & Investment Income for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Dec 2024 value amounting to $13.8 million.

  • Mirum Pharmaceuticals' Interest & Investment Income fell 6.28% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.5 million, marking a year-over-year decrease of 12.89%. This contributed to the annual value of $13.8 million for FY2024, which is 0.41% up from last year.
  • As of FY2024, Mirum Pharmaceuticals' Interest & Investment Income stood at $13.8 million, which was up 0.41% from $13.7 million recorded in FY2023.
  • Over the past 5 years, Mirum Pharmaceuticals' Interest & Investment Income peaked at $13.8 million during FY2024, and registered a low of $366,000 during FY2021.
  • Moreover, its 3-year median value for Interest & Investment Income was $13.7 million (2023), whereas its average is $10.5 million.
  • As far as peak fluctuations go, Mirum Pharmaceuticals' Interest & Investment Income plummeted by 76.52% in 2021, and later surged by 953.83% in 2022.
  • Over the past 5 years, Mirum Pharmaceuticals' Interest & Investment Income (Yearly) stood at $1.6 million in 2020, then slumped by 76.52% to $366,000 in 2021, then surged by 953.83% to $3.9 million in 2022, then soared by 256.11% to $13.7 million in 2023, then rose by 0.41% to $13.8 million in 2024.